VVA
KYTX icon

Vida Ventures Advisors’s Kyverna Therapeutics KYTX Stock Holding History

Vida Ventures Advisors’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$27.1M Hold
4,523,924
– – 92.41% 1
2025
Q2 		$13.9M Hold
4,523,924
– – 87.24% 1
2025
Q1 		$8.73M Hold
4,523,924
– – 64.02% 1
2024
Q4 		$16.9M Hold
4,523,924
– – 11.56% 3
2024
Q3 		$22.1M Hold
4,523,924
– – 15.96% 3
2024
Q2 		$33.9M Hold
4,523,924
– – 37.11% 2
2024
Q1 		$112M Buy
+4,523,924
New +$126M 62.43% 1

Other funds holding KYTX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MPM
MBB Public Markets Chicago, Illinois $839M AUM 20.48% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vida Ventures Advisors's KYTX Position: Q3 2025 in Review

Vida Ventures Advisors held its Kyverna Therapeutics (KYTX) position steady in Q3 2025 at 4,523,924 shares worth $27.1M. The position accounts for 92.41% of the portfolio, ranked #1.

Vida Ventures Advisors first reported a position in KYTX in Q1 2024 and has held it in 7 quarters since. The position peaked at $112M in Q1 2024. 75 funds tracked by Wall St. Rank hold KYTX as of Q3 2025.

  • Vida Ventures Advisors held 4,523,924 shares of Kyverna Therapeutics worth $27.1M as of Q3 2025.
  • Vida Ventures Advisors left its Kyverna Therapeutics share count unchanged in Q3 2025.
  • Kyverna Therapeutics made up 92.41% of Vida Ventures Advisors's portfolio in Q3 2025, its #1 holding.
  • Vida Ventures Advisors first reported a position in Kyverna Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • Vida Ventures Advisors's Kyverna Therapeutics position peaked at $112M in Q1 2024.
  • 75 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2025.

Based on Vida Ventures Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.